Quarterly report pursuant to Section 13 or 15(d)

INVESTMENT (Details)

v3.24.1.1.u2
INVESTMENT (Details) - USD ($)
3 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Equity Method Investments and Joint Ventures [Abstract]    
ILiAD Loss from continuing operations $ (10,091,000) $ (3,466,000)
ILiAD Comprehensive loss $ (9,470,000) $ (9,911,000)